You have 9 free searches left this month | for more free features.

Adoptive Treatment

Showing 1 - 25 of 719

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

Recruiting
  • Pancreatic Cancer
  • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
  • Shanghai, China
    Changhai Hospital affiliated to Naval Medical University
Mar 13, 2023

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

Not yet recruiting
  • Cancer
    • (no location specified)
    Feb 7, 2023

    Metastatic Melanoma Trial in Tampa (procedure, drug, other)

    Active, not recruiting
    • Metastatic Melanoma
    • Surgery
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023

    Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

    Not yet recruiting
    • Lupus Nephritis
    • Type 1 Diabetes Mellitus
    • autologous adoptive T regulatory cell transfer.
    • Cairo, Egypt
      Ain shams university, faculty of medicine
    Sep 30, 2022

    After Adoptive Transfer of Genetically Modified Cell Products

    Recruiting
    • Relapsed Hematologic Malignancy
    • Refractory Hematologic Malignancy
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Feb 6, 2023

      Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)

      Withdrawn
      • Advanced Hepatocellular Carcinoma
      • GDKM-100 injection
      • Zhuhai, Guangdong, China
        Zhuhai People'S Hospital
      Jan 16, 2023

      Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

      Completed
      • Progressive Multifocal Leukoencephalopathy
      • PyVST
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • iNKT Cells
      • +2 more
      • Beijing, Beijing, China
        Beijing Youan Hospital,Capital Medical University
      Jul 24, 2023

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (haplo-identical cells (donor), umbilical cord blood unit

      Recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • haplo-identical cells (donor)
      • umbilical cord blood unit (CBU)
      • New York, New York
        Weill Cornell Medical College
      Dec 14, 2022

      Tumors Trial in Gainesville, Waterloo, Springfield (Screening Platform)

      Terminated
      • Neoplasms
      • Screening Platform
      • Gainesville, Florida
      • +2 more
      Dec 1, 2022

      Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

      Recruiting
      • Hematologic Malignancy
      • +4 more
      • Palliative Care
      • Usual Care
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Jan 24, 2023

      Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount

      Recruiting
      • Triple Negative Breast Cancer
      • Nonsmall Cell Lung Cancer
        • Rocky Mount, North Carolina
          Accellacare of Rocky Mount -Dr. Bondy
        May 26, 2023

        Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

        Active, not recruiting
        • Metastatic Melanoma
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Nov 8, 2022

        HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

        Recruiting
        • HER2-positive Breast Cancer
        • Dendritic Cell (DC1) Vaccine
        • +3 more
        • Tampa, Florida
          Moffitt Cancer Center
        Dec 28, 2022

        HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

        Recruiting
        • HNSCC
        • +5 more
        • DP CD8 TIL
        • +2 more
        • Portland, Oregon
          Providence Portland Medical Center
        Jun 5, 2023

        Rapid Autopsy and Procurement of Cancer Tissue

        Recruiting
        • Thymus Tumors
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Aug 20, 2022

          Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)

          Recruiting
          • Acute Myeloid Leukemia in Children
          • CIML NK Cell Infusion
          • CD3+ T Cell Product Infusion
          • Saint Louis, Missouri
            Washington University School of Medicine
          Oct 26, 2022

          Sarcoma Trial in Turin (Autologous CIK)

          Recruiting
          • Sarcoma
          • Autologous CIK
          • Turin, Italy
            AOU Città della Salute e della Scienza di Torino - Presidio Infa
          Aug 11, 2022

          Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

          Recruiting
          • Acute Myeloid Leukemia
          • Graft cell infusion
          • +6 more
          • Saint Louis, Missouri
            Washington University School of Medicine
          Jan 29, 2023

          Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific

          Recruiting
          • Cytomegalovirus Infections
          • +2 more
          • CMV specific adoptive t-cells
          • Cleveland, Ohio
            University Hospitals Cleveland Medical Center, Case Comprehensiv
          Jul 26, 2022

          Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

          Active, not recruiting
          • Prostate Cancer
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Nov 28, 2022

          Late Complication From Kidney Transplant Trial in San Francisco (Treg infusion)

          Completed
          • Late Complication From Kidney Transplant
          • Treg infusion
          • San Francisco, California
            University of California, San Francisco
          Jul 11, 2022

          Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

          Recruiting
          • Malignant Glioma
          • High Grade Glioma
          • TTRNA-DC vaccines with GM-CSF
          • +4 more
          • Birmingham, Alabama
          • +2 more
          Feb 2, 2023

          Peripheral Blood Mononuclear Cells From Healthy People for

          Recruiting
          • Healthy Volunteer
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 20, 2022